US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Articles published by Amphastar Pharmaceuticals, Inc.

News headline image
Amphastar Receives FDA Approval for Vasopressin
From Amphastar Pharmaceuticals, Inc.
Via AccessWire
Tickers AMPH
News headline image
Amphastar Pharmaceuticals to Present at the Jefferies Healthcare Conference
From Amphastar Pharmaceuticals, Inc.
Via AccessWire
Tickers AMPH
News headline image
Amphastar Receives FDA Approval for Regadenoson
From Amphastar Pharmaceuticals, Inc.
Via AccessWire
Tickers AMPH
News headline image
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2022
From Amphastar Pharmaceuticals, Inc.
Via AccessWire
Tickers AMPH
News headline image
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 9, 2022
From Amphastar Pharmaceuticals, Inc.
Via AccessWire
Tickers AMPH
News headline image
Amphastar Receives FDA Approval for Ganirelix Acetate Injection
From Amphastar Pharmaceuticals, Inc.
Via AccessWire
Tickers AMPH
News headline image
Amphastar Pharmaceuticals to Present at the 21st Annual Needham Virtual Healthcare Conference
From Amphastar Pharmaceuticals, Inc.
Via AccessWire
Tickers AMPH
News headline image
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2021
From Amphastar Pharmaceuticals, Inc.
Via AccessWire
Tickers AMPH
News headline image
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 10th, 2022
From Amphastar Pharmaceuticals, Inc.
Via AccessWire
Tickers AMPH
News headline image
Amphastar Receives FDA Tentative Approval for Vasopressin
From Amphastar Pharmaceuticals, Inc.
Via AccessWire
Tickers AMPH
News headline image
Amphastar Pharmaceuticals to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference
From Amphastar Pharmaceuticals, Inc.
Via AccessWire
Topics Regulatory Compliance
Tickers AMPH
News headline image
Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference
From Amphastar Pharmaceuticals, Inc.
Via AccessWire
Topics Regulatory Compliance
Tickers AMPH
News headline image
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2021
From Amphastar Pharmaceuticals, Inc.
Via AccessWire
Topics Regulatory Compliance
Tickers AMPH
News headline image
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8th, 2021
From Amphastar Pharmaceuticals, Inc.
Via AccessWire
Topics Regulatory Compliance
Tickers AMPH
News headline image
Amphastar Pharmaceuticals to Present at the Wells Fargo 2021 Virtual Healthcare Conference
From Amphastar Pharmaceuticals, Inc.
Via AccessWire
Topics Regulatory Compliance
Tickers AMPH
News headline image
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2021
From Amphastar Pharmaceuticals, Inc.
Via AccessWire
Topics Regulatory Compliance
Tickers AMPH
News headline image
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 9th, 2021
From Amphastar Pharmaceuticals, Inc.
Via AccessWire
Topics Regulatory Compliance
Tickers AMPH